Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPoint
Beta&Vols
Tech ChartsRisk, Price & Valuation of Marksans Pharma (MARKSANS)
Valuation Ratio Profitability Ratio Solvency Ratio Efficiency Ratio
Risk , Price and Valuations Ratios of Marksans Pharma
| Year | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 | Mar-12 | Mar-11 | Mar-10 | Mar-09 | Mar-08 | Mar-07 | Mar-06 | Mar-05 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | 6.92 | 6.92 | 6.41 | 4.56 | 5.83 | 2.86 | 1.87 | 0.805 | 0.216 | 1.92 | 2.67 | 1.87 | 1.19 | -4.86 | -6.07 | -0.273 | -0.227 | 0.429 | 1.89 | 6.37 | 16.45 |
| EPS Cash | 8.58 | 8.58 | 7.63 | 5.66 | 6.71 | 3.48 | 2.44 | 1.29 | 1.03 | 2.71 | 3.13 | 2.32 | 1.27 | -4.79 | -6.03 | -0.262 | -0.216 | 0.437 | 1.86 | 6.37 | 16.45 |
| Price By Book | 4.88 | 3.33 | 1.68 | 1.55 | 2.31 | 0.895 | 1.85 | 2.70 | 4.28 | 4.26 | 6.53 | 6.19 | 0 | -0.359 | -1.27 | 1.12 | 1.00 | 4.56 | 1.45 | 6.87 | 0 |
| Price To Sales | 4.63 | 3.16 | 1.58 | 1.25 | 1.49 | 0.502 | 1.02 | 1.42 | 2.52 | 2.12 | 3.18 | 1.46 | 0 | 0.171 | 0.272 | 0.502 | 0.419 | 2.45 | 0.757 | 2.76 | 0 |
| Earning Yield | 3.11 | 4.56 | 9.11 | 10.03 | 11.67 | 20.57 | 7.49 | 2.54 | 0.458 | 4.14 | 4.32 | 7.81 | -294.69 | -269.76 | -5.57 | -5.54 | 2.38 | 3.70 | 2.79 | ||
| Price To Cash Flow | 43.77 | 29.89 | 12.32 | 18.76 | 9.74 | 2.44 | 37.28 | 25.86 | 137.25 | 61.53 | 16.40 | 14.20 | 0 | -0.974 | -1.27 | 10.65 | 7.53 | 27.95 | -5.08 | 55.23 | 0 |
| Retention Ratio | 0.913 | 0.928 | 0.962 | 0.943 | 0.983 | 0.748 | 0.942 | 0.925 | -0.929 | 0.771 | 0.947 | 0.866 | 0.998 | 1.00 | 0 | 0 | 1.01 | 0 | 0 | 0 | 0 |
| Price / EPS (PE) | 32.15 | 21.95 | 10.98 | 9.97 | 8.57 | 4.86 | 13.36 | 39.33 | 218.35 | 24.14 | 23.16 | 12.81 | 0 | -0.339 | -0.371 | -17.95 | -18.06 | 41.95 | 27.04 | 35.90 | 0 |
| Price / Earning Growth (PEG) | 2.76 | 0.272 | -0.460 | 0.083 | 0.092 | 0.101 | 0.144 | -2.46 | -0.855 | 0.536 | -0.0447 | 0 | -0.0009 | -0.0007 | 0.247 | 0.234 | -0.294 | -0.094 | -0.0487 | 0 | |
| Enterprise Value to Revenue Ratio | 4.43 | 2.88 | 1.40 | 1.04 | 1.36 | 0.440 | 1.10 | 1.52 | 2.64 | 2.19 | 3.00 | 1.77 | 0 | 0.171 | 0.272 | 0.502 | 0.419 | 2.45 | 0.757 | 2.76 | 0 |
| Enterprise Value to EBITDA Ratio | 18.95 | 12.31 | 6.51 | 5.17 | 5.39 | 2.64 | 8.26 | 16.65 | 41.47 | 13.91 | 12.87 | 9.33 | 0 | -0.604 | -0.540 | 7.19 | 5.15 | 15.64 | 6.49 | 16.43 | 0 |
| Market Capitalization To Sales Ratio | 4.63 | 3.16 | 1.58 | 1.25 | 1.49 | 0.502 | 1.02 | 1.42 | 2.52 | 2.12 | 3.18 | 1.46 | 0 | 0.171 | 0.272 | 0.502 | 0.419 | 2.45 | 0.757 | 2.76 | 0 |
| Cost Of equity (CAPM) | 0.186 | 0.180 | 0.148 | 0.158 | 0.163 | 0.128 | 0.196 | 0.179 | 0.271 | 0.237 | 0.105 | -0.0433 | 0.100 | 0.157 | 0.158 | 0.168 | 0.178 | 0 | 0 | 0 | 0 |
Compound Annual Growth Rate (CAGR) of Valuation Ratios Marksans Pharma
| Period | 1 Year | 3 Year | 5 Year | 7 Year | 10 Year |
|---|---|---|---|---|---|
| EPS | 0.00 | 14.88 % | 19.34 % | 35.99 % | 9.98 % |
| EPS Cash | 0.00 | 14.91 % | 19.81 % | 31.14 % | 10.62 % |
| Price By Book | 46.46 % | 46.63 % | 40.42 % | 8.85 % | -2.87 % |
| Price To Sales | 46.46 % | 54.78 % | 55.98 % | 18.41 % | 3.83 % |
| Earning Yield | -31.72 % | -32.31 % | -31.46 % | 2.92 % | -3.23 % |
| Price To Cash Flow | 46.46 % | 32.63 % | 78.16 % | 7.81 % | 10.32 % |
| Retention Ratio | -1.56 % | -1.07 % | 4.08 % | -0.185 % | -0.363 % |
| Price / EPS (PE) | 46.46 % | 47.74 % | 45.91 % | -2.84 % | 3.33 % |
| Price / Earning Growth (PEG) | % | % | % | % | % |
| Enterprise Value to Revenue Ratio | 53.96 % | 61.98 % | 58.71 % | 16.56 % | 3.99 % |
| Enterprise Value to EBITDA Ratio | 53.96 % | 54.21 % | 48.29 % | 1.87 % | 3.94 % |
| Market Capitalization To Sales Ratio | 46.46 % | 54.78 % | 55.98 % | 18.41 % | 3.83 % |
| Cost Of equity (CAPM) | 3.03 % | 5.47 % | 7.71 % | 0.528 % | 5.89 % |
Formula of common Valuation Ratios
About TSR TECH Strength / Valuation / Growth
TSR Tech Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, Moving Avg, Chart Patterns, Candlestick and proprietary algorithms.Technical Strength is calculate from 1 Min Tick to One Month Tick.
TSR Growth analyses dozen of Historical , MRQ, TTM Parameters, Returns of Individual Stocks vis-a-vis sector , broad based Index to access Growth Potential.
TSR Value analyses dozen of Historical , MRQ, TTM Parameters, Returns of Individual Stocks vis-a-vis sector , broad based Index to access its value.
This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share.